跳至主要内容
临床试验/JPRN-jRCTb030200391
JPRN-jRCTb030200391招募中3 期

The Efficacy of Platelet-Rich-Plasma for prevention of the knee joint cartilage degeneration after anterior cruciate ligament reconstruction: a single-blind randomized trial - The Efficacy of Platelet-Rich-Plasma for prevention of the knee joint cartilage degeneration after anterior cruciate ligament reconstruction

Yoshitomo Saita0 个研究点目标入组 80 人开始时间: 2021年3月2日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 50age old(—)
性别
All

入选标准

  • 1 At the time of obtaining consent, the age is between 20 and 50
  • 2 Male and female
  • 3 Kellgren-Lawrence classification 2 or less
  • 4 Single bundle reconstruction surgery using semitendinosus tendon as reconstruction ligament
  • 5 First injury
  • 6 BMI is less than 35
  • 7 Those who have received a sufficient explanation, fully understood, and obtained free written consent.
  • 8 In addition, those who the doctor deems appropriate

排除标准

  • 1 Ligament compound injury (posterior cruciate ligament, lateral support mechanism)
  • 2 Merge of medial collateral ligament injuries requiring repair
  • 3 Femoro-Tibial Angle: FTA left and right difference is 10 degrees or more
  • 4 Whole body motor disease
  • 5 Patients with malignant neoplasms currently being treated
  • 6 Patients with active infectious disease (including HBV, HCV, HTLV-1, HIV, syphilis)
  • 7 Rheumatoid arthritis
  • 8 Blood disease
  • 9 Mental illness
  • 10 pregnant
  • 11 Drug addict
  • 12 Person on dialysis
  • 13 Those under 20 and over 50
  • 14 Patients who cannot measure communication
  • 15 Patients who are judged not suitable by the research doctor

研究者

发起方
Yoshitomo Saita

相似试验